Sort
23,748 grants matching “melanoma”
Project 1
$286,918Jiyoung Ahn · New York University School Of Medicine · P50 · FY2020 · CA
Novel Single, Dual and Multitargeted Inhibitors of RTKs
$286,901Aleem Gangjee · Duquesne University · R01 · FY2006 · CA
Biospecimen and Pathology Core
$286,862Xiaowei Xu · Wistar Institute · P50 · FY2022 · CA
Targeting Evolving Therapy Resistance
$286,843Yael P Mosse · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA
Characterization of Human Oral Cancer Initiating Cell (CIC) Antigens
$286,781Qiao Li · University Of Michigan At Ann Arbor · R56 · FY2014 · DE
Melanocyte boundary interactions in development and neoplasia
$286,726David M Parichy · University Of Washington · R01 · FY2013 · GM
Prevalence and Progression of Monoclonal Gammopathies
$286,707S Vincent Rajkumar · Mayo Clinic Rochester · R01 · FY2007 · CA
Prevalence and Progression of Monoclonal Gammopathies
$286,707S Vincent Rajkumar · Mayo Clinic Rochester · R01 · FY2008 · CA
EMMPRIN: from biology to molecular mechanism
$286,672Elan Z Eisenmesser · University Of Colorado Denver · R01 · FY2011 · GM
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations
$286,658Brian C Miller · Univ Of North Carolina Chapel Hill · K08 · FY2024 · CA
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations
$286,658Brian C Miller · Univ Of North Carolina Chapel Hill · K08 · FY2023 · CA
CORE--MICROARRAY & ANALYSIS SHARED SERVICE
$286,657Michael John Becich · University Of Pittsburgh At Pittsburgh · P30 · FY2008 · CA
Validation of Grm1 as a Therapeutic Target in Melanoma
$286,624James S Goydos · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2011 · CA
In vivo real-time detection of circulating melanoma cells
$286,607Vladimir P Zharov · Univ Of Arkansas For Med Scis · R01 · FY2010 · CA
EMMPRIN: from biology to molecular mechanism
$286,551Elan Z Eisenmesser · University Of Colorado Denver · R01 · FY2012 · GM
IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
$286,549University Of Texas Sw Med Ctr/Dallas · R01 · FY2005 · CA
IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
$286,549University Of Texas Sw Med Ctr/Dallas · R01 · FY2004 · CA
IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
$286,549University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · CA
The Role of Beta-catenin Signaling in Malignant Melanoma
$286,479Marcus W Bosenberg · University Of Vermont & St Agric College · R01 · FY2006 · CA
ESTABLISHING THE ROLE OF DEPLOYMENTS IN MELANOMA IN THE MILITARY
$286,477University Of Texas Medical Branch At Galveston · · FY2021 · Defense Health Agency
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$286,470Ashish Ranjan · Ut Southwestern Medical Center · R37 · FY2023 · CA
QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer
$286,470Gordon M Ringold · Quadriga Biosciences, Inc. · R44 · FY2023 · CA
Synergy of the innate and acquired immune responses in tumor immunology
$286,422Randolph J. Noelle · Dartmouth College · R01 · FY2009 · CA
The Development of Screening Assays For Novel Inhibitors Of ARNO And Its Effector
$286,412Dean Yaw Li · University Of Utah · R01 · FY2013 · CA
Investigation of the WRAMP Structure, a Mechanism for Directional Cell Migration
$286,400Natalie G Ahn · University Of Colorado · R01 · FY2019 · GM